These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4506236)

  • 21. Phenytoin-related cerebellar degeneration without seizures.
    Rapport RL; Shaw CM
    Ann Neurol; 1977 Nov; 2(5):437-9. PubMed ID: 617582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a new convulsant for anticonvulsant screening.
    Banziger R; Hane D
    Arch Int Pharmacodyn Ther; 1967 Jun; 167(2):245-9. PubMed ID: 4383444
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the mechanism of action of diphenylhydantoin.
    Pincus JH; Grove I; Marino BB; Glaser GE
    Arch Neurol; 1970 Jun; 22(6):566-71. PubMed ID: 4245359
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of anticonvulsants on spiking activity induced by cortical freezing in cats.
    Hori M; Ito T; Yoshida K; Shimizu M
    Epilepsia; 1979 Feb; 20(1):25-36. PubMed ID: 369853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of diphenylhydantoin administered during gestation and lactation on the motor development and cerebellar histology of the young rat].
    Desor D; Royer RJ; Netter P; Guedenet JC; Faure G; Krafft B; Grignon G
    C R Seances Soc Biol Fil; 1978; 172(6):1057-62. PubMed ID: 159092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in sensitivity of mice to anticonvulsant drugs following bilateral olfactory bulb ablations.
    Ueki S; Araki Y; Watanabe S
    Jpn J Pharmacol; 1977 Apr; 27(2):183-92. PubMed ID: 328966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of diphenylhydantoin on the spontaneous activity of Purkinje, nucleus interpositus, red nucleus and motor cortex cells.
    Fernández-Guardiola A; Calvo JM; Condés-Lara M
    Electroencephalogr Clin Neurophysiol; 1979 Sep; 47(3):358-68. PubMed ID: 90605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined study of the pattern of spontaneous activity of cerebellar Purkinje cells and phenytoin serum levels in the rat.
    Latham A; Paul DH
    Epilepsia; 1980 Dec; 21(6):597-610. PubMed ID: 7439130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendritic, axonal, and spinal pathology of the Purkinje cells and the neurons of the dentate nucleus after long-term phenytoin administration: a case report.
    Mavroudis IA; Manani MG; Petrides F; Kiourexidou M; Njau SN; Costa VG; Baloyannis SJ
    J Child Neurol; 2013 Oct; 28(10):1299-304. PubMed ID: 22965563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of diphenylhydantoin on gamma aminobutyric acid (GABA) and succinate activity in rat Purkinje cells.
    Hitchcock E; Gabra-Sanders T
    J Neurol Neurosurg Psychiatry; 1977 Jun; 40(6):565-9. PubMed ID: 903771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of antiepileptic drugs on estrogen-induced electrographic spike-wave discharge.
    Julien RM; Fowler GW; Danielson MG
    J Pharmacol Exp Ther; 1975 May; 193(2):647-56. PubMed ID: 1095714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of diphenylhydantoin and phenobarbital on intestinal calcium transport in the rat.
    Koch HU; Kraft D; von Herrath D; Schaefer K
    Epilepsia; 1972 Dec; 13(6):829-34. PubMed ID: 4509174
    [No Abstract]   [Full Text] [Related]  

  • 33. Interrelation at plasmatic level between antiepileptic drugs and lipids. Its implications in the efficiency of treatment in epilepsy. I. Changes induced by phenobarbital or/and diphenylhydantoin in serum lipids.
    Rogozea R; Florea-Ciocoiu V; Bălăiţă C; Luca N
    Neurol Psychiatr (Bucur); 1980; 18(2):69-77. PubMed ID: 7414244
    [No Abstract]   [Full Text] [Related]  

  • 34. A comparison of the anticonvulsant properties of 2-diethylaminopento-4-ynoyl-2',6'-xylidide (WY 21745) with lignocaine, phenytoin, phenobarbitone and trimethadione.
    Southgate PJ
    Arch Int Pharmacodyn Ther; 1971 Jun; 191(2):405-14. PubMed ID: 5559826
    [No Abstract]   [Full Text] [Related]  

  • 35. Electrophysiologic properties of diphenylhydantoin.
    Caracta AR; Damato AN; Josephson ME; Ricciutti MA; Gallagher JJ; Lau SH
    Circulation; 1973 Jun; 47(6):1234-41. PubMed ID: 4709540
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of diphenylhydantoin and cholinergic agents on the neuronally isolated cerebral cortex.
    Krip G; Vazquez AJ
    Electroencephalogr Clin Neurophysiol; 1971 May; 30(5):391-8. PubMed ID: 4103624
    [No Abstract]   [Full Text] [Related]  

  • 37. Relation of laboratory evaluation to clinical effectiveness of antiepileptic drugs.
    Millichap JG
    Epilepsia; 1969 Jun; 10(2):315-28. PubMed ID: 4308261
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclic adenosine monophosphate: possible mediator for norepinephrine effects on cerebellar Purkinje cells.
    Siggins GR; Hoffer BJ; Bloom FE
    Science; 1969 Sep; 165(3897):1018-20. PubMed ID: 4308638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substantia nigra regulates action of antiepileptic drugs.
    Turski L; Andrews JS; Löschmann PA; Bressler K; Bortolotto ZA; Calderazzo-Filho LS; Cavalheiro EA
    Brain Res; 1990 Jun; 520(1-2):232-9. PubMed ID: 2207634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of Cerebellar Evoked Potentials by a peripheral action of diphenylhydantoin.
    Anderson RJ; Raines A
    Arch Int Pharmacodyn Ther; 1975 Nov; 218(1):144-55. PubMed ID: 1212012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.